LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Thromboelastography Applied in Diagnosing Normal and Complicated Pregnancies

By LabMedica International staff writers
Posted on 04 May 2022
Image: Thromboelastography has been applied in diagnosing normal and complicated pregnancies (Photo courtesy of Hemologix)
Image: Thromboelastography has been applied in diagnosing normal and complicated pregnancies (Photo courtesy of Hemologix)

During pregnancy, the coagulation system in women undergoes considerable changes to prevent bleeding. If the coagulation system in pregnant women is not functioning optimally, incidents such as bleeding and miscarriage are prone to occur; if the coagulation system in pregnant women is hyperfunctional, the risk of venous thrombosis is high.

At present, many indicators such as activated partial prothrombin time and prothrombin time are used to detect blood coagulation function in the body. Thromboelastography (TEG), as a currently accessible laboratory test, can reflect the dynamic changes in the coagulation process and has high application value in evaluating platelet function.

Hematologists at the Affiliated Hospital of Hubei Polytechnic University (Huangshi, China) collected samples for 156 pregnant women with normal pregnancy (NP) and 58 women with threatened abortion (TA), 13 with missed abortion (MAb), 25 with embryo arrest (EA), four with fetal death (FD), six with a history of abnormal pregnancy (HAP), and seven with antiphospholipid antibody syndrome (AA).

TEG was performed using a BVCA-I thromboelastometer. The parameters R, K, α-angle, MA, LY-30, G, and coagulation index (CI) were analyzed. Partial correlation analysis was used to analyze correlation between groups of data. LSD-t test and Dunnett's T3 test were used to analyze continuous variables. Ordinal categorical variables were compared using ordinal logistic regression analysis and estimate odds ratio of risk factors. A receiver operating characteristic (ROC) curve was constructed to detect the ability of TEG to recognize various parameters, and areas under the curve were compared using Delong's test for diagnosing pregnancy-related diseases.

The scientists reported that there was no correlation between the data of NP and TA, and NP and FD groups; MAb had a negative effect on the MA parameter in TEG; EA had a negative effect on the MA and G parameters; HAP had a negative effect on the CI parameter and a positive effect on the R parameter; AA had a negative effect on the CI parameter. The team found that TEG parameters were different between some patient groups and control groups. For example, the CI value of the TA group was decreased, and the ratio of the angle value lower than the upper limit of the normal reference value was higher than that of the NP group, indicating that the coagulation function is low, and there could be a problem of inadequate fibrin levels or function.

The authors concluded that TEG has a good clinical significance in the diagnosis of TA, MAb, EA, AA, and HAP. The study was published on April 24, 2022 in the Journal of Clinical Laboratory Analysis.

Related Links:
Affiliated Hospital of Hubei Polytechnic University

Gold Member
Collection and Transport System
PurSafe Plus®
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Homocysteine Quality Control
Liquichek Homocysteine Control
CBM Analyzer
Complete Blood Morphology (CBM) Analyzer

Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more